About Teletype
Join
Acumen Research
@acumenresearch
Business
February 25, 2020

ePharmacy Industry to Reach $155.4 Bn, Globally by 2026 at 14.5% CAGR

ePharmacy Market (By Drug Type: Prescription Drugs, Over the Counter (OCT) Drugs; By Product Type: Dental, Skin Care, Vitamins, Cold and Flu, Weight Loss, Other) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

According to ARC, the global ePharmacy market is forecasted to show a remarkable CAGR around 14.5% during the forecast time frame and reach around US$ 155.4 billion by 2026.

The epharmacy market growth is mainly driven by the penetration of the internet, ecommerce, increasing awareness related to chronic diseases, improved healthcare infrastructures, rise in the aging population, growth in a number of patients, and large customer base in developed and developing countries are driving the growth of the market.

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1746

Acumen Research & Consulting, a global provider of market research studies, in a recently published report titled "ePharmacy Market (By Drug Type: Prescription Drugs, Over the Counter (OCT) Drugs; By Product Type: Dental, Skin Care, Vitamins, Cold and Flu, Weight Loss, Other) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026".

North America dominated the global epharmacy market in the year 2018. The well-developed healthcare infrastructures, high-speed internet, many healthcare insurance policies, a large number of medical products available in the epharmacy, along with a strong distribution channel, cost-efficient, increase in expenses in healthcare, rise in the elderly population, and rise in awareness related to chronic diseases are accelerating the growth of epharmacy market. In addition, the Food and Drug Administration (FDA) in the US emphasis on actively apprising the native concerning the rules and regulation of epharmacy and make them informed about the safety of purchasing medicines online. The USA and Canada are the strongest economies that can be the utmost important market in this region. The European region is anticipated to exhibit the second-largest share in the epharmacy market. However, the existence of prominent players and rising pharmaceuticals needs, mostly baby boomers are fueling the growth of the global epharmacy market in the coming years. The regularity authorizes taking initiatives to increase awareness related to the purchase of prescription drugs through epharmacy which abolish the extra cost incurred in the supply of medicines from producers to end-users removing the long distribution channels. Moreover, shift of consumer behavior towards online purchasing which is encouraging consumers to buy medicines from epharmacy sites due to high price discounts, easily accessibility of information, home delivery, presence high network speed, high adoption of ecommerce sites, and large customer base further grow the demand for epharmacy in the region during the forecast period.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/epharmacy-market

Asia-Pacific is anticipated to project the highest CAGR over the forecast period. The increasing penetration of high-speed internet with a smartphone in urban and rural areas, soaring adoption of ecommerce platforms, presence of the great patient groups, rising target population, rise in the popularity of ecommerce websites are estimated to fuel the epharmacy in this region. In addition, regularity authorities are taking steps to and investing funds to upgrade the healthcare infrastructures, offline pharmacy retails are unavailable to meet the rapidly rising needs are inducing towering demand for online availability of drugs, increasing awareness level about chronic diseases among citizens are also accelerating the growth of global market in the near forthcoming years. Moreover, in the Asia Pacific region, there are many rapidly emerging countries that becoming a profitable market. Not only China and India are through numerous economic changes, but they also have a huge population that is a ready-made market for a large number of products and services. Japan is another strong economy that has advance technology and high-speed network are few factors that can enhance the global epharmacy market over the forecast period.

Over the counter segment dominated the epharmacy market on the basis of drug type in the year 2018. It is drugs that are sold to customers directly without prescription by the physician such as vitamins, supplements, cough syrups to get instant relief from minor symptoms. Additionally, rising initiatives by many countries to develop the healthcare sector, such as, Safe India medicines supported 60 new startups that emerged in India for epharmacy. Many developing are don't have well-developed hospitals that's why most of the population are depending on over the counter drugs as they don't have consult doctors or any lab tests, lower the economic burden, and easily available and convenient in over the counter further anticipated raising the segment over the forecast period.

Related Reports

Some of the leading competitors are Walgreen Co., Rowlands PharmacyWalmart Stores, Inc., The Kroger Co., DocMorris, Optium Rx, Inc.,Banner Health, CVS Health Corporation, Giant Eagle, Inc., and Express Script Holding Company.

Some of the key observations regarding epharmacy industry include:

  • In January 2019, Meds online pharmacy of Swedish has invested US$ 5.5 million to expand its business across Europe and other European countries.
  • In June 2015, Rite Aid crop has acquired Rx Option that provide mail pharmacy services including prescription drugs which has facilitated to enter into the field of epharmacy.
  • In March 2019, 1mg, an Indian online pharmacy garnered LegitScript certification from the National association of Boards of Pharmacy (NABP), USA making it the first organization in India to earn the said certification. The certification has increased the trust of the consumers in the company products.
  • In November 2016, Netmeds Marketplace Limited has acquired Pluss which is hyperlogical drugs delivery app. This acquisition has enabled the company to focus on enhancing the company's online app.
  • In 2016, Safe Medicines India has supported 60 new startups for online pharmacy in India.

Market Segmentation

Market By Drug Type

  • Prescription Drugs
  • Over the Counter (OCT) Drugs

Market By Product Type

  • Dental
  • Skin Care
  • Vitamins
  • Cold and Flu
  • Weight Loss
  • Other

Market By Geography

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • Germany
  • France
  • Spain
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

- What is the overall structure of the market?

- What was the historical value and what is the forecasted value of the market?

- What are the key product level trends in the market?

- What are the market level trends in the market?

- Which of the market players are leading and what are their key differential strategies to retain their stronghold?

- Which are the most lucrative regions in the market space?

Request for Customization@ https://www.acumenresearchandconsulting.com/request-customization/1746

TABLE OF CONTENT

CHAPTER 1. DRUG TYPE OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of EPharmacy
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. EPharmacy Market By Drug Type
1.2.2.1. Global EPharmacy Market Revenue and Growth Rate Comparison By Drug Type(2015-2026)
1.2.2.2. Global EPharmacy Market Revenue Share By Drug Typein 2018
1.2.2.3. Prescription Drugs
1.2.2.4. Over the Counter (OCT) Drugs
1.2.3. EPharmacy Market By Product Type
1.2.3.1. Global EPharmacy Market Revenue and Growth Rate Comparison By Product Type(2015-2026)
1.2.3.2. Global EPharmacy Market Revenue Share By Product Typein 2018
1.2.3.3. Dental
1.2.3.4. Skin Care
1.2.3.5. Vitamins
1.2.3.6. Cold and Flu
1.2.3.7. Weight Loss
1.2.3.8. Other
1.2.7 EPharmacy Market by Geography
1.2.3.9. Global EPharmacy Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.3.10. North America EPharmacy Market Revenue and Growth Rate (2015-2026)
1.2.3.11. Europe EPharmacy Market Revenue and Growth Rate (2015-2026)
1.2.3.12. Asia-Pacific EPharmacy Market Revenue and Growth Rate (2015-2026)
1.2.3.13. Latin America EPharmacy Market Revenue and Growth Rate (2015-2026)
1.2.3.14. Middle East and Africa (MEA) EPharmacy Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Product Type and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING EPHARMACY ANALYSIS
3.1. Capacity and Commercial Production Date of Global EPharmacy Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global EPharmacy Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global EPharmacy Major Manufacturers in 2018
3.4. Raw Product Types Sources Analysis of Global EPharmacy Major Manufacturers in 2018

CHAPTER 4. EPHARMACY MARKETBY DRUG TYPE
4.1. Global EPharmacy Revenue By Drug Type
4.2. Prescription Drugs
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Over the Counter (OCT) Drugs
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. EPHARMACY MARKET BY PRODUCT TYPE
5.1. Global EPharmacy Revenue By Product Type
5.2. Dental
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Skin Care
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Vitamins
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Cold and Flu
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Weight Loss
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.7. Other
5.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA EPHARMACY MARKET BY COUNTRY
6.1. North America EPharmacy Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America EPharmacy Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S.EPharmacy Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE EPHARMACY MARKET BY COUNTRY
7.1. Europe EPharmacy Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe EPharmacy Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC EPHARMACY MARKET BY COUNTRY
8.1. Asia-Pacific EPharmacy Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific EPharmacy Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA EPHARMACY MARKET BY COUNTRY
9.1. Latin America EPharmacy Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America EPharmacy Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
9.4. Mexico
9.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST & AFRICA EPHARMACY MARKET BY COUNTRY
10.1. Middle East & Africa EPharmacy Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East & Africa EPharmacy Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. GCC
10.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
10.4. South Africa
10.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
10.5. Rest of Middle East & Africa
10.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE
11.1. CVS Health Corporation
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Giant Eagle, Inc.
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Walmart Stores, Inc.
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. The Kroger Co.
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. DocMorris
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Optium Rx, Inc.
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. Express Script Holding Company
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. Walgreen Co.
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. Rowlands Pharmacy
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
11.10. Banner Health
11.10.1. Company Snapshot
11.10.2. Overview
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. Key Developments
11.10.6. Strategies
11.11. Others
11.11.1. Company Snapshot
11.11.2. Overview
11.11.3. Financial Overview
11.11.4. Product Portfolio
11.11.5. Key Developments
11.11.6. Strategies

CHAPTER 12. RESEARCH APPROACH
12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report@ https://www.acumenresearchandconsulting.com/buy-now/0/1746

If you would like to place an order or have any questions, please feel free to contact at sales@acumenresearchandconsulting.com| +1-407-915-4157 OR +1-408-900-9135

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Contact Us:

Phone: +14079154157 | +14089009135

Website: https://www.acumenresearchandconsulting.com

Follow Us: LinkedIN | Twitter

Acumen Research
February 25, 2020, 11:55
0 views
0 reactions
0 replies
0 reposts